Department of Microbiology and Infectious Diseases, Nara Medical University, Nara, Japan.
Department of Otolaryngology-Head and Neck Surgery, Nara Medical University, Nara, Japan.
Ann Lab Med. 2020 Jan;40(1):27-32. doi: 10.3343/alm.2020.40.1.27.
Mutations in the quinolone resistance-determining regions (QRDRs) of DNA gyrase () and topoisomerase IV () are linked to fluoroquinolone (FQ) resistance. We developed a mismatched PCR-restriction fragment length polymorphism (RFLP) assay to detect mutations in the and QRDRs associated with FQ resistance in .
Based on the conserved sequences of and , two primer sets were designed for mismatched PCR-RFLP to detect mutations in (codons 83 and 87) and (codons 80 and 84) by introducing an artificial restriction enzyme cleavage site into the PCR products. This assay was evaluated using 58 strains and 37 other Acinetobacter strains that have been identified by RNA polymerase β-subunit gene sequence analysis.
PCR amplification of and was successful for all strains. In 11 FQ -susceptible strains, the and PCR products were digested by the selected restriction enzymes at the site containing (codons 83 and 87) and (codons 80 and 84). PCR products from 47 FQ-resistant strains containing mutations in and were not digested by the restriction enzymes at the site containing the mutation. As for the non- strains, although amplification products for were obtained for 28 strains, no amplification product was obtained for any strain.
This assay specifically amplified and from and detected and mutations with FQ resistance.
DNA 回旋酶()和拓扑异构酶 IV()的喹诺酮类药物耐药决定区(QRDRs)的突变与氟喹诺酮类(FQ)耐药有关。我们开发了一种错配 PCR-限制性片段长度多态性(RFLP)检测方法,用于检测与 FQ 耐药相关的 中的 QRDR 突变。
根据 和 的保守序列,设计了两套引物用于错配 PCR-RFLP,通过在 PCR 产物中引入人工限制性内切酶切割位点,检测 (密码子 83 和 87)和 (密码子 80 和 84)中的突变。该检测方法使用了 58 株 和 37 株其他已通过 RNA 聚合酶 β-亚单位基因序列分析鉴定的不动杆菌菌株进行了评估。
所有 菌株的 和 PCR 扩增均成功。在 11 株 FQ 敏感株中,选择的限制性内切酶在包含 (密码子 83 和 87)和 (密码子 80 和 84)的位点切割 和 PCR 产物。含有 和 突变的 47 株 FQ 耐药株的 PCR 产物不能被突变位点的限制酶切割。对于非 株,虽然有 28 株获得了 的扩增产物,但任何一株都没有获得 的扩增产物。
该检测方法特异性地从 和 扩增 和 ,并检测到与 FQ 耐药相关的 和 突变。